In this issue:
FIX gene therapy in haemophilia B
FXI antisense oligonucleotide for venous thrombosis prevention
Long-acting rFIXFc for perioperative management in haemophilia B
Ruxolitinib for polycythaemia vera
FVIII products and inhibitors in treatment-naïve children with severe haemophilia A
D-dimer to select first unprovoked VTE patients who can stop anticoagulation
Prognostic factors in acquired haemophilia A
Platelet transfusions in platelet consumptive disorders
Fondaparinux for suspected HIT
Antepartum dalteparin for preventing pregnancy complications in thrombophilia
Please login below to download this issue (PDF)